FIELD: medicine. SUBSTANCE: method involves administering CINT preparation according to known mode of application. The patients are divided into two groups as belonging to early morning and to daytime hypertension group. The first group receives CINT once a day in the evening and the second group patients receive CINT in the morning. The initial dose of the preparation is 0.2 mg and then from 0.2 to 0.6 mg. EFFECT: enhanced effectiveness in influencing vegetative disorder manifestations.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING X METABOLISM SYNDROME | 1997 |
|
RU2132190C1 |
| METHOD OF TREATING PATIENTS WITH CARDIOVASCULAR DISEASES | 2013 |
|
RU2543468C2 |
| METHOD OF TREATING PATIENTS SUFFERING FROM CARDIOVASCULAR DISEASES | 2009 |
|
RU2392919C1 |
| METHOD OF TREATING PATIENTS SUFFERING ARTERIAL HYPERTENSION | 2012 |
|
RU2508087C1 |
| METHOD FOR PREDICTING ISCHEMIC CARDIAC DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION | 2006 |
|
RU2316995C1 |
| METHOD OF TREATMENT OF ISOLATED SYSTOLIC ARTERIAL HYPERTENSION OF 1 DEGREE IN PATIENTS IN EARLY PERIOD OF OLD AND SENILE AGE | 2019 |
|
RU2726071C1 |
| METHOD OF TREATING ESSENTIAL ARTERIAL HYPERTENSION AT BACKGROUND OF OBESITY | 2013 |
|
RU2563832C2 |
| METHOD OF TREATING MOOD DISTURBANCES AND ARRHYTHMIA OF ARTERIAL PRESSURE IN PATIENTS SUFFERING FROM HYPERTENSIVE DISEASE ASSOCIATED WITH ALEXITHYMIA | 2000 |
|
RU2161969C1 |
| METHOD FOR EVALUATING EFFICIENCY IN TREATING PATIENTS WITH ARTERIAL HYPERTENSION | 2002 |
|
RU2229260C1 |
| METHOD FOR INDIVIDUAL PREVENTION OF OESTROGEN-DEPENDENT DISEASES IN HEALTHY FEMALES AND FEMALES SUFFERING CARDIOVASCULAR RISK FACTORS AT AGE OF 45-60 YEARS OLD | 2013 |
|
RU2527357C1 |
